Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
CYTK
— Cytokinetics, Incorporated
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 5, 2026
REVENUE
$19.4M
+9.0%
NET MARGIN
-1064.5%
-33.6 PTS
EPS
-$1.67
-12.1%
FREE CASH FLOW
-$151.4M
-2.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →